Long-term effectiveness of vedolizumab in inflammatory bowel disease: a national study based on the Swedish National Quality Registry for Inflammatory Bowel Disease (SWIBREG) - Eriksson, C; Marsal, J; Bergemalm, D (Scand J Gastroenterol, 2017)
et al.